K211308 · Aon Co., Ltd. · EIH · Oct 4, 2021 · Dental
Device Facts
Record ID
K211308
Device Name
INNI-CERA
Applicant
Aon Co., Ltd.
Product Code
EIH · Dental
Decision Date
Oct 4, 2021
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 872.6660
Device Class
Class 2
Intended Use
INNI-CERA is indicated for use by dental technicians in the construction of custom made all ceramic restorations. Coping Crown Inlay & Onlay Veneer Bridge(3-unit anterior bridges)
Device Story
INNI-CERA is a zirconia-based slurry used by dental technicians to fabricate custom ceramic restorations via additive manufacturing. Input consists of patient dental data converted to an STL file; processed by a DLP 3D printer using a photocuring lamination method (420nm UV light) to cure the zirconia-binder mixture. The resulting model undergoes sintering to achieve final material properties. Used in dental laboratories; output is a custom dental restoration (crown, bridge, etc.) intended to improve patient oral function and aesthetics. Benefits include precise anatomical fit based on digital patient data. Device is single-use and non-sterile.
Clinical Evidence
No clinical performance testing was performed. Substantial equivalence is supported by non-clinical bench testing in accordance with ISO 6872:2015 (flexural strength, chemical solubility, coefficient of thermal expansion, radioactivity) and biocompatibility testing per ISO 10993 series (cytotoxicity, sensitization, irritation, systemic toxicity, genotoxicity, carcinogenicity).
Technological Characteristics
Material: Zirconia slurry. Manufacturing: DLP 3D printing (photocuring lamination, 420nm UV). Standards: ISO 6872:2015 (Type I Class III), ISO 10993-1. Properties: Flexural strength >300 MPa, chemical solubility <100µg/cm², uranium-238 <1.0Bq/g. Non-sterile, single-use.
Indications for Use
Indicated for dental technicians constructing custom all-ceramic restorations including copings, crowns, inlays, onlays, veneers, and 3-unit anterior bridges.
Regulatory Classification
Identification
Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 4, 2021
Aon Co., Ltd Sanghwa Myung Regulatory Affair Consultant E&m D-1474, 230, Simin-daero, Dongan-gu Anyang, Gyeonggi-do 14067 SOUTH KOREA
Re: K211308
Trade/Device Name: Inni-cera Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder For Clinical Use Regulatory Class: Class II Product Code: EIH Dated: August 4, 2021 Received: August 6, 2021
Dear Sanghwa Myung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see
https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael E. Adjodha, M.ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known)
#### K211308
Device Name INNI-CERA
Indications for Use (Describe)
INNI-CERA is indicated for use by dental technicians in the construction of custom made all ceramic restorations.
Coping Crown Inlay & Onlay Veneer Bridge(3-unit anterior bridges)
| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
## CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
# AON Co., Ltd
# 510(k) Summary
# K211308
Aon Co., Ltd Submitter: A-Dong 2508,2201, 17, Gosan-ro 148beon-gil, Gunposi, Gyeonggi-do, 15850, South Korea Telephone: +82-31-689-5012 Fax: +82-31-689-5019 E-mail: jinhd0411@aoninni.com
Contact Person: Requlatory Affair/Sang Hwa Myung Telephone: +82-70-7807-0550 FAX: +82-31-388-9263 E-mail: mshenmc@gmail.com
Date 510(k) summary prepared: August 4th , 2021
#### Trade Name: INNI-CERA (BCM-W500, BCM-W1000)
Common Name: Dental Zirconia Material Regulation Name: Porcelain Powder for Clinical Use Classification: Class II Product Code: EIH Classification Panel: Dental Regulation Numbers: 21 CFR 872.6660 Type of 510(k) submission: Traditional
Description of Device:
INNI-CERA is intended for use in fabricating custom-made ceramic restorations using a 3D printer additive manufacturing process. It is a product that is used after fabricating and sintering with a mixture of zirconia powder and binder. The DLP 3D printer used to fabricate the INNICERA is a photocuring lamination method using an STL file (dental restoration shape), which is irradiated with light in the strong UV region (420nm) to cure the photocurable mixture to form a model. This product corresponds to ISO 6872 Type I Class III. The material is used in a 3D printer, which prints the shape determined by an STL file converted from patients' teeth data. 3D printer is not included with the product. INNI-CERA cannot be reused.
{4}------------------------------------------------
Indication for use:
INNI-CERA is indicated for use by dental technicians in the construction of custom-made ceramic restorations. Coping Crown Inlay & Onlay Veneer Bridge (3-unit anterior bridges)
## Predicate Device:
Manufacturer: Ivoclar Vivadent, Incorporated
510(k) Number: K051705 Trade Name: IPS e.max ZirCAD Regulation Name: Porcelain Powder for Clinical Use Regulation Numbers: 21 CFR 872.6660 Product Code: EIH Classification: Class II
## Substantial Equivalence:
Comparison table is as follows.
## Table 1: Substantial equivalence comparison
| Contents | Subject Device | Predicate Device |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | Aon Co., Ltd | Ivoclar Vivadent, Incorporated |
| 510(k)Number | Pending | K051705 |
| Trade Name | INNI-CERA | IPS e.max ZirCAD |
| Indication for Use | INNI-CERA is indicated<br>for use by dental<br>technicians in the<br>construction of custom<br>made all ceramic<br>restorations.<br><br>Crown<br>Inlay & Onlay<br>Veneer<br>Bridge(3-unit anterior<br>bridges) | IPS e.max ZirCAD<br>consists of machinable<br>zirconia blocks for the<br>preparation of full<br>ceramic crowns, onlays<br>and 3- and 4-unit bridges<br>and inlay bridges<br>(anterior and<br>molar.) |
| Material | Zirconia | Zirconia |
| Material Type | Slurry | Block |
| Biocompatibility | According to EN ISO<br>10993-1 | According to EN ISO<br>10993-1 |
| Flexural Strength | >300 MPa<br>(meeting ISO 6872<br>requirements) | >300 MPa<br>(meeting ISO 6872<br>requirements) |
| Chemical Solubility | < 100µg/cm²<br>(meeting ISO 6872<br>requirements) | < 100µg/cm²<br>(meeting ISO 6872<br>requirements) |
| Radioactivity | Activity<br>concentration of<br>uranium238 less<br>than 1.0Bq g-1 | Activity<br>concentration of<br>uranium238 less<br>than 1.0Bq g-1 |
{5}------------------------------------------------
| | (meeting ISO 6872<br>requirements) | (meeting ISO 6872<br>requirements) |
|-------------|------------------------------------|------------------------------------|
| Sintering | YES | YES |
| Single Use | YES | YES |
| Non-sterile | YES | YES |
- Discussion
The information provided in this subject device is equivalence of indication for use, material, biocompatibility, Flexural Strength, Chemical Solubility, Radioactivity with the predicate device (K051705). The minor difference is that INNI-CERA's material type is slurry and K051705 is a block type. It is a biocompatible material according to ISO 10993-1. Therefore, the difference in material types will not raise concern about safety and effectiveness.
## 2) Reference Device
Manufacturer: Enlighten Materials Co., Ltd 510(k) Number: K191590 Trade Name: AA temp temporary restoration 3D printing photoreactive resin Regulation Name: Temporary crown and bridge resin Regulation Numbers: 872.3770 Product Code: EBG Classification: Class II
| Contents | Subject Device | Reference Device | Comparison<br>Comment |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | Aon Co., Ltd | Enlighten<br>Materials Co., Ltd | - |
| 510(k)Number | Pending | K191590 | - |
| Trade Name | INNI-CERA | AA temp<br>temporary<br>restoration 3D<br>printing<br>photoreactive resin | - |
| Indication for Use | INNI-CERA is<br>indicated for use<br>by dental<br>technicians in the<br>construction of<br>custom made all<br>ceramic<br>restorations.<br>Crown<br>Inlay & Onlay<br>Veneer<br>Bridge(3-unit<br>anterior bridges) | AA temp<br>temporary<br>restoration 3D<br>printing<br>photoreactive resin<br>is a light-curable<br>polymerizable<br>resin to<br>fabricate, by<br>additive<br>manufacturing,<br>temporary<br>crowns or bridges. | The manufacturing<br>of restorations<br>using a 3D printer<br>is the same, the<br>materials are<br>different, but the<br>use of dental<br>materials for teeth<br>is the same. |
| Biocompatibility | According to EN<br>ISO 10993-1 | According to EN<br>ISO 10993-1 | Substantial<br>Equivalent |
| Production type | 3D printing | 3D printing | Substantial<br>Equivalent |
| Non-sterile | YES | YES | Substantial<br>Equivalent |
{6}------------------------------------------------
#### Discussion
A reference device is a dental manufactured by a 3d printer. K191590 is resin material but INNI-CERA is Zirconia material and It is a different material, but it is a biocompatible material according to ISO 10993-1. Both products manufacture dental restorations using 3D printer additive manufacturing. K191590 and subject device are used in a similar anatomical location for a similar physiological purpose. Therefore, the difference material will not raise concern of the safety and effectiveness.
#### Biocompatibility testing:
INNI-CERA dental zirconia materials were evaluated according to ISO 10993-1. The results of this test confirmed that it met the biocompatibility requirements. Biocompatibility testing. including cytotoxicity, sensitization, oral mucosal irritation, Acute Systemic Toxicity, Pyrogen Test, Subchronic systemic toxicity, Mammalian Erythrocyte Micronucleus Test (Carcinogenicity), AMES Test (Genotoxicity) was completed according to the following standards: ISO 10993-1 Biological Evaluation of Medical Devices –Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process ISO 10993-5 Biological Evaluation of Medical Devices - Part 5 Cytotoxicity ISO 10993-10 Biological Evaluation of Medical Devices Part 10: Tests for irritation and skin sensitization ISO 10993-12 Biological evaluation of medical devices-- ISO 10993-3: Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity, and reproductive and developmental toxicity, ISO 10993-11: Biological evaluation of medical devices -. Part 11: Tests for systemic.
## Non-clinical Performance Data:
Bench Test:
In accordance with ISO 6872:2015 (Dentistry – Ceramic materials), the product must meet the requirements for flexural strength, chemical solubility, coefficient of thermal expansion, and radioactivity.
The Predicate device of IPS e.max ZirCAD (K051705) meets the requirements of the applicable class, as detailed in the table under Technological characteristics. The performance of INN-CERA meets the requirements of non-clinical bench testing was conducted to support substantial equivalence.
Shelf life testing, INNI-CERA has shelf life of 3 month. The shelf testing has been through accelerated aging test and confirm the performance accordance with ISO 6872:2015
## Risk Management
A risk analysis was conducted based on ISO 14971:2012 Medical devices – Application of risk management to medical devices
## . Clinical Data:
No clinical performance testing was performed.
{7}------------------------------------------------
## Conclusion
In accordance with ISO 6872:2015 (Dentistry – Ceramic materials), the product must meet the requirements for flexural strength, chemical solubility, coefficient of thermal expansion, and radioactivity. The predicate IPS e.max ZirCAD(K051705) meet the requirements of the applicable Class, as detailed in Table under Technological Characteristics.
The performance of INN-CERA meets the requirements of the non-clinical bench testing conducted to support substantial equivalence. Based on the available information, the subject device and the predicates are similar indication for use, material, performance data and biocompatibility.
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the information provided in this premarket notification that we conclude that substantially equivalent with predicate device.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.